These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Matrix metalloproteinases MMP-3 and MMP-1 levels in sera and synovial fluids in patients with rheumatoid arthritis and osteoarthritis. Mahmoud RK; El-Ansary AK; El-Eishi HH; Kamal HM; El-Saeed NH Ital J Biochem; 2005; 54(3-4):248-57. PubMed ID: 16688934 [TBL] [Abstract][Full Text] [Related]
4. Soluble interleukin 6 (IL-6) receptor and IL-6 levels in serum and synovial fluid of patients with different arthropathies. Usón J; Balsa A; Pascual-Salcedo D; Cabezas JA; Gonzalez-Tarrio JM; Martín-Mola E; Fontan G J Rheumatol; 1997 Nov; 24(11):2069-75. PubMed ID: 9375862 [TBL] [Abstract][Full Text] [Related]
5. IgG antibodies to type II collagen reflect inflammatory activity in patients with rheumatoid arthritis. Kim WU; Yoo WH; Park W; Kang YM; Kim SI; Park JH; Lee SS; Joo YS; Min JK; Hong YS; Lee SH; Park SH; Cho CS; Kim HY J Rheumatol; 2000 Mar; 27(3):575-81. PubMed ID: 10743792 [TBL] [Abstract][Full Text] [Related]
6. Levels of hepatocyte growth factor in synovial fluid and serum of patients with rheumatoid arthritis and release of hepatocyte growth factor by rheumatoid synovial fluid cells. Yukioka K; Inaba M; Furumitsu Y; Yukioka M; Nishino T; Goto H; Nishizawa Y; Morii H J Rheumatol; 1994 Dec; 21(12):2184-9. PubMed ID: 7699616 [TBL] [Abstract][Full Text] [Related]
7. Increased synovial fluid levels of interleukin-12, sCD25 and sTNF-RII/sTNF-RI ratio delineate a cytokine pattern characteristic of immune arthropathies. Ribbens C; André B; Kaye O; Kaiser MJ; Bonnet V; de Groote D; Franchimont N; Malaise MG Eur Cytokine Netw; 2000 Dec; 11(4):669-76. PubMed ID: 11125312 [TBL] [Abstract][Full Text] [Related]
8. Preferential induction of prodestructive matrix metalloproteinase-1 and proinflammatory interleukin 6 and prostaglandin E2 in rheumatoid arthritis synovial fibroblasts via tumor necrosis factor receptor-55. Alsalameh S; Amin RJ; Kunisch E; Jasin HE; Kinne RW J Rheumatol; 2003 Aug; 30(8):1680-90. PubMed ID: 12913922 [TBL] [Abstract][Full Text] [Related]
9. Synovial fluid levels of anti-cyclic citrullinated peptide antibodies and IgA rheumatoid factor in rheumatoid arthritis, psoriatic arthritis, and osteoarthritis. Caspi D; Anouk M; Golan I; Paran D; Kaufman I; Wigler I; Levartovsky D; Litinsky I; Elkayam O Arthritis Rheum; 2006 Feb; 55(1):53-6. PubMed ID: 16463412 [TBL] [Abstract][Full Text] [Related]
10. [Practical significance of cytokine determination in joint fluid in patients with arthroses or rheumatoid arthritis]. Neidel J; Schulze M; Sova L; Lindschau J Z Orthop Ihre Grenzgeb; 1996; 134(4):381-5. PubMed ID: 8928570 [TBL] [Abstract][Full Text] [Related]
11. Th1/Th17 cytokine profiles in patients with reactive arthritis/undifferentiated spondyloarthropathy. Singh R; Aggarwal A; Misra R J Rheumatol; 2007 Nov; 34(11):2285-90. PubMed ID: 17937463 [TBL] [Abstract][Full Text] [Related]
12. Inadequately low serum levels of steroid hormones in relation to interleukin-6 and tumor necrosis factor in untreated patients with early rheumatoid arthritis and reactive arthritis. Straub RH; Paimela L; Peltomaa R; Schölmerich J; Leirisalo-Repo M Arthritis Rheum; 2002 Mar; 46(3):654-62. PubMed ID: 11920401 [TBL] [Abstract][Full Text] [Related]
13. Circulating levels of matrix metalloproteinases MMP-3 and MMP-1, tissue inhibitor of metalloproteinases 1 (TIMP-1), and MMP-1/TIMP-1 complex in rheumatic disease. Correlation with clinical activity of rheumatoid arthritis versus other surrogate markers. Keyszer G; Lambiri I; Nagel R; Keysser C; Keysser M; Gromnica-Ihle E; Franz J; Burmester GR; Jung K J Rheumatol; 1999 Feb; 26(2):251-8. PubMed ID: 9972954 [TBL] [Abstract][Full Text] [Related]
14. Synovial fluid levels of tumor necrosis factor alpha and oncostatin M correlate with levels of markers of the degradation of crosslinked collagen and cartilage aggrecan in rheumatoid arthritis but not in osteoarthritis. Manicourt DH; Poilvache P; Van Egeren A; Devogelaer JP; Lenz ME; Thonar EJ Arthritis Rheum; 2000 Feb; 43(2):281-8. PubMed ID: 10693867 [TBL] [Abstract][Full Text] [Related]
15. Extravasation into synovial tissue induces CCL20 mRNA expression in polymorphonuclear neutrophils of patients with rheumatoid arthritis. Schlenk J; Lorenz HM; Haas JP; Herrmann M; Hohenberger G; Kalden JR; Röllinghoff M; Beuscher HU J Rheumatol; 2005 Dec; 32(12):2291-8. PubMed ID: 16331752 [TBL] [Abstract][Full Text] [Related]
16. High levels of interleukin 13 in rheumatoid arthritis sera are modulated by tumor necrosis factor antagonist therapy: association with dendritic cell growth activity. Tokayer A; Carsons SE; Chokshi B; Santiago-Schwarz F J Rheumatol; 2002 Mar; 29(3):454-61. PubMed ID: 11908556 [TBL] [Abstract][Full Text] [Related]
17. Cytokine levels in serum and synovial fluid of patients with juvenile rheumatoid arthritis. Madson KL; Moore TL; Lawrence JM; Osborn TG J Rheumatol; 1994 Dec; 21(12):2359-63. PubMed ID: 7699643 [TBL] [Abstract][Full Text] [Related]
18. Elevated concentrations of monocyte derived cytokines in synovial fluid of children with enthesitis related arthritis and polyarticular types of juvenile idiopathic arthritis. Saxena N; Aggarwal A; Misra R J Rheumatol; 2005 Jul; 32(7):1349-53. PubMed ID: 15996076 [TBL] [Abstract][Full Text] [Related]
19. Synovial fluid induced nuclear factor-kappaB DNA binding in a monocytic cell line. Lehmann T; Nguyen LQ; Handel ML J Rheumatol; 2000 Dec; 27(12):2769-76. PubMed ID: 11128662 [TBL] [Abstract][Full Text] [Related]
20. Synovial fluid CD146 (MUC18), a marker for synovial membrane angiogenesis in rheumatoid arthritis. Neidhart M; Wehrli R; Brühlmann P; Michel BA; Gay RE; Gay S Arthritis Rheum; 1999 Apr; 42(4):622-30. PubMed ID: 10211875 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]